Should You Buy Kenvue Inc. (KVUE)’s Shares?

Kenvue Inc. (NYSE:KVUE) is one of the 10 Best Stocks to Buy According to Billionaire Glenn Dubin’s Highbridge Capital.

Consumer health company Kenvue Inc. (NYSE:KVUE)’s shares are down by 8.8% over the past year and are up by 10% year-to-date. Several analysts have discussed the firm in 2026. On April 15th, Citi cut the share price target to $19 from $20 and kept a Neutral rating on the shares. The coverage was part of Citi’s coverage of the broader sector, as it remarked that investors would be focused on margin risk and the impact of high oil prices. Earlier, on March 6th, Barclays had increased the share price target to $19 from $18 and kept an Equal Weight rating on the shares. However, on April 14th, Barclays reduced the target to $18. As was the case with Citi, the bank also discussed the impact of higher input costs on Kenvue Inc. (NYSE:KVUE)’s business.

hould You Buy Kenvue Inc. (KVUE)’s Shares?

Source: Pixabay

Highbridge Capital first disclosed holding Kenvue Inc. (NYSE:KVUE)’s in its filings for the third quarter of 2023. Back then, it disclosed holding 31,408 shares that were worth $630,673. Then, it removed the stake in Q4. The fund disclosed holding 1.1 million Kenvue Inc. (NYSE:KVUE) shares in its Q4 2025 filings and the number of shares remained unchanged in Q1 2026.

While we acknowledge the risk and potential of KVUE as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than KVUE and that has 10,000% upside potential, check out our report about the cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy.

Disclosure: None. Follow Insider Monkey on Google News.

1281292 - 11759070 - 1